Patent · US Active

Combination therapies for treatment of cancer

US10682356B2 · kind B2 · utility

7Cited by

95References

1Claims

0Family size

Assignee

TOLERO PHARMACEUTICALS, INC. · US

Inventors

David J. Bearss · Alpine, US
Steven L. Warner · Sandy, US
Adam Siddiqui-Jain · South Jordan, US
Clifford J. Whatcott · Lehi, US
Wontak Kim · Lehi, US

Key dates

Filing date	Oct 28, 2019
Grant date	Jun 16, 2020
Priority date	—
Expiry date	Oct 28, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Combination therapies for treatment of cancer are provided. The disclosed methods comprise administration of a cyclin-dependent kinase inhibitor and a DNA methyltransferase inhibitor to a mammal in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.